Lavinia Ferrante di Ruffano

Medicine & Life Sciences

1. Skin Neoplasms 100%
2. Melanoma 99%
3. Dermoscopy 96%
4. Routine Diagnostic Tests 90%
5. SARS Virus 76%
6. Systematic Reviews 72%
7. Artificial Intelligence 69%
8. Point-of-Care Systems 58%
9. Severe Acute Respiratory Syndrome 55%
10. Coronavirus Infections 54%
11. Confidence Intervals 52%
12. Skin 48%
13. Basal Cell Carcinoma 46%
14. Meta-Analysis 43%
15. Computer-Assisted Diagnosis 43%
16. Publications 41%
17. Randomized Controlled Trials 36%
18. Infections 34%
19. Guidelines 34%
20. Endocrine System Diseases 34%
21. Biomedical Technology Assessment 32%
22. Antigens 32%
23. Cell Biology 31%
24. Organizations 30%
25. Positron Emission Tomography Computed Tomography 28%
26. Intelligence 27%
27. Clinical Trials 25%
28. Optical Coherence Tomography 25%
29. United States Food and Drug Administration 25%
30. Spectrum Analysis 25%
31. Rare Diseases 25%
32. Databases 24%
33. Sensitivity and Specificity 23%
34. Sentinel Lymph Node Biopsy 19%
35. Reverse Transcription 19%
36. Datasets 18%
37. MEDLINE 17%
38. Tomography 17%
39. Magnetic Resonance Imaging 17%
40. Squamous Cell Carcinoma 16%
41. Congresses 16%
42. Preprints 16%
43. Neoplasm Metastasis 15%
44. Whole Body Imaging 15%
45. Data Accuracy 15%
46. Patient Selection 15%
47. Polymerase Chain Reaction 14%
48. Antibodies 14%
49. Validation Studies 14%
50. Critical Pathways 13%